BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8499143)

  • 1. Current issues in the management of clinical stage I testicular teratoma.
    Horwich A
    Eur J Cancer; 1993; 29A(7):933-4. PubMed ID: 8499143
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours.
    Bottomley D; Fisher C; Hendry WF; Horwich A
    Br J Urol; 1990 Oct; 66(4):420-4. PubMed ID: 2224437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
    Culine S
    Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of poor prognosis teratoma.
    Welch RS; Wilkinson PM
    Br J Hosp Med; 1996 Sep 4-17; 56(5):222-4. PubMed ID: 8879702
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer of the testis: a new paradigm.
    Einhorn LH
    Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mature teratoma following chemotherapy in bilateral testicular tumors--a critical contribution].
    Fichte A; von Paris V
    Z Urol Nephrol; 1985 Jun; 78(6):317-21. PubMed ID: 4036384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
    Williams SB; Kacker R; Steele GS; Richie JP
    Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed?
    Solé-Balcells F; Villavicencio H; Germá R
    Prog Clin Biol Res; 1989; 303():759-62. PubMed ID: 2780671
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences in the treatment of advanced nonseminomatous testicular tumor].
    Scheiber K; Salzer M; Bartsch G
    Wien Klin Wochenschr; 1986 Aug; 98(15):481-6. PubMed ID: 2429460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapeutic treatment regimens for germinal testicular tumors].
    Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
    Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
    [No Abstract]   [Full Text] [Related]  

  • 16. Postchemotherapy surgery in nonseminoma.
    Steyerberg EW; Keizer HJ; Sleijfer DT
    J Clin Oncol; 1997 Sep; 15(9):3165-6. PubMed ID: 9294480
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgery following chemotherapy for metastatic testicular teratoma.
    Whillis D; Coleman RE; Lessells AM; Hargreave TB; Cornbleet MA; Howard GC
    Br J Urol; 1991 Sep; 68(3):292-5. PubMed ID: 1913071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
    Foster RS; Baniel J; Leibovitch I; Curran M; Bihrle R; Rowland R; Donohue JP
    J Urol; 1996 Jun; 155(6):1943-5. PubMed ID: 8618293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
    Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
    Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
    Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
    Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.